Liraglutide

Liraglutide: Easing Nausea, Injecting Correctly and What Happens After Stopping

Liraglutide is a GLP-1 receptor agonist injected under the skin once a day. In type 2 diabetes it lowers blood sugar, and at a higher dose it is licensed for weight reduction. The typical hurdles in everyday life are nausea during the dose-escalation phase, mistakes in injection technique and the effect after stopping: appetite, weight and blood sugar usually come back.

See more detail

Liraglutide: dose steps, injection sites and nausea at a glance

A daily injection reminder, a dose-escalation plan and a tolerability history in one place — free in the brite app.

Track liraglutide

Contents

  1. At a Glance: Technical Data Sheet
  2. How it works: a satiety hormone as a medicine
  3. Dosing: two indications, two dose ladders
  4. Using it: the pen step by step
  5. Side effects: the gut and the serious exceptions
  6. Easing in to limit nausea: what really helps
  7. The stopping effect: what happens after you stop
  8. Interactions
  9. Liraglutide, semaglutide, tirzepatide: how they differ
  10. Special situations: pregnancy, anaesthesia, kidneys, costs
  11. Liraglutide experiences: what patients really ask
  12. FAQ: Common questions about liraglutide

1. At a Glance: Technical Data Sheet

PropertyDetails
Active ingredientLiraglutide
ATC codeA10BJ02
Drug classGLP-1 receptor agonist (incretin mimetic)
Dosage formsPre-filled pen for injection under the skin (subcutaneous); separate products for type 2 diabetes and for weight reduction, plus a fixed combination with a long-acting insulin
Half-lifeAbout 13 hours — hence one injection a day
Maximum daily doseAccording to the SmPC, 1.8 mg in type 2 diabetes and 3.0 mg for weight reduction; your individual dose is set by the practice
Onset of effectBlood sugar and appetite change within days; the effect on weight is assessed over weeks to months
Prescription statusPrescription-only medicine
Notable featureGradual dose escalation because of nausea; daily rather than weekly dosing; for weight reduction usually paid for out of pocket
Table scrolls to the right

2. How it works: a satiety hormone as a medicine

After every meal, the gut releases the hormone GLP-1 (glucagon-like peptide-1). It signals the pancreas to release more insulin, holds back glucagon, the hormone that raises blood sugar, slows the emptying of the stomach and tells the brain that you are full. The body's own GLP-1 is broken down within a few minutes. Liraglutide is a slightly modified copy that binds to proteins in the blood and therefore works for around a day.¹

Its strengths and its weaknesses both follow from this mechanism:

  • Blood sugar: insulin release only rises when blood sugar is raised. On its own, liraglutide therefore rarely causes hypoglycaemia — in combination with insulin or sulfonylureas, however, it can.
  • Appetite and weight: the satiety signal in the brain and the more slowly emptying stomach lead many people to eat less. That is the basis of the effect on weight.
  • Nausea: the same slowed stomach and the effect on the vomiting centre cause the typical gastrointestinal complaints. The body gets used to them over weeks — hence the gradual dose escalation.
What liraglutide is licensed for. In type 2 diabetes, liraglutide is used in addition to diet and exercise, usually alongside metformin; in people with a high cardiovascular risk, a large study (LEADER) showed that it reduced serious cardiovascular events. At a higher dose it is licensed for weight reduction in obesity or in overweight with related conditions, including for adolescents aged 12 and over. Which product fits is decided by the treating practice.¹,²

3. Dosing: two indications, two dose ladders

Liraglutide is never started at the target dose but increased step by step. The figures below describe the schedule according to the SmPC and are not instructions for dosing yourself — the pace and the target dose are set by the treating practice.¹,³

Type 2 diabetesWeight reduction
Starting dose0.6 mg daily for at least one week — only to get used to it, not yet an effective blood sugar dose0.6 mg daily
IncreaseTo 1.2 mg and, if needed, to 1.8 mg after at least one more weekIn weekly steps via 1.2 · 1.8 · 2.4 mg up to 3.0 mg
Maintenance dose1.2 or 1.8 mg3.0 mg
Checking successBlood sugar and HbA1c over timeAccording to the SmPC, stop if at least 5% of the starting weight has not been lost after 12 weeks on 3.0 mg
Table scrolls to the right

Two points are often overlooked. First: the weekly steps are minimum intervals, not an obligation. If a step is poorly tolerated, the practice can postpone the increase. Second: if you also take insulin or a sulfonylurea such as glimepiride, the dose of these medicines often has to be reduced at the start to avoid hypoglycaemia — and measuring your blood sugar more often then becomes part of the routine.

4. Using it: the pen step by step

Liraglutide is injected once a day, independently of meals and at a time you are free to choose, but that should stay as consistent as possible. The technique is quickly learned — mistakes still creep in, mostly when changing the needle and with the holding time.¹

  1. Check the pen. The right product, the expiry date, a clear and colourless solution. Do not use a cloudy or discoloured solution.
  2. A new needle for every injection. Reused needles become blunt, get blocked and make the injection more painful.
  3. Flow check only with a new pen. Before using a new pen for the first time, check once that liquid comes out — after that, not with every dose.
  4. Set the dose and choose the site. Abdomen, thigh or upper arm. Change the injection point within the area each time, and do not inject into scars or hardened areas.
  5. Insert, press, hold. Press the button all the way down and then leave the needle in the skin for a few more seconds — the instructions for use say how long. If you pull it out too early, you lose part of the dose.
  6. Dispose of the needle. Use a puncture-proof container, and store the pen without the needle and with the cap on.
Storage and injection sites. Unopened pens belong in the fridge (not the freezer); according to the SmPC, a pen in use keeps for one month at room temperature up to 30 °C or in the fridge. Do not use pens that have been frozen. If you always inject in the same spot, you risk hardening of the tissue, which impairs absorption. More in the guides storing medications correctly and injecting insulin correctly — the injection technique is very similar.

Missed dose: do not inject a double amount. The package leaflets for liraglutide pens describe up to what point a missed dose can be made up on the same day and when it is skipped — follow the rule for your product. After longer breaks (a limit of about three days is often given), treatment is usually restarted at a low dose, because the gut can lose its tolerance. How to proceed in your case is something to clarify with the practice; general rules are set out under missed a medication.

Which dose step, which injection site?

brite reminds you every day, keeps track of your dose escalation and records how you tolerate each step.

Create an injection plan

5. Side effects: the gut and the serious exceptions

Most of liraglutide's side effects affect the digestive tract and are a direct consequence of how it works. Nausea and diarrhoea are very common; vomiting, constipation, a feeling of fullness, belching and heartburn are common. They occur mainly at the start and after each dose increase, and for most people they subside over days to weeks.¹,⁴

Other common complaints are headache, tiredness, dizziness, reactions at the injection site and a slightly raised resting pulse. Hypoglycaemia occurs mainly in combination with insulin or sulfonylureas.

Rare but serious

  • Gallstones and inflammation of the gallbladder: the risk is increased, partly because of the rapid weight loss. Warning signs are colicky pain in the right upper abdomen, fever or yellowing of the skin — see gallstones.
  • Acute inflammation of the pancreas: rare but dangerous. According to the SmPC, liraglutide is not restarted if pancreatitis is confirmed.
  • Dehydration and kidney damage: persistent vomiting or diarrhoea can dehydrate you and worsen kidney function — drink enough and seek medical advice early.
  • Thyroid: in animal studies, tumours of certain thyroid cells (C cells) occurred; in humans a connection has not been established. With a history of medullary thyroid cancer, the decision is weighed up particularly critically.
  • Suicidal thoughts: a review by the European Medicines Agency in 2024 found no established causal link with GLP-1 receptor agonists. Changes in mood should nevertheless always be raised.⁵
Warning signs of pancreatitis. Severe, persistent pain in the upper abdomen, often radiating to the back, with or without vomiting: stop injecting liraglutide and have it checked by a doctor immediately; with very severe pain or circulatory problems, go to the emergency department or call 112 (emergency number in Germany). The same applies to signs of a severe allergic reaction such as breathlessness or swelling of the face and throat.

6. Easing in to limit nausea: what really helps

Nausea is the most common reason why people stop liraglutide again in the first few weeks. It is not a sign that the medicine "doesn't suit you", but usually a transitional phase. What matters is keeping it small enough for you to reach the point where your body has adjusted.⁴

What helps

  • Smaller portions, eaten more slowly — the stomach empties more slowly. If you eat as you used to, you overfill it. Stop as soon as you are full, not when your plate is empty.
  • Cut down on fatty and very sweet foods — they stay in the stomach longest and are the most common triggers.
  • Drink throughout the day — small sips rather than large amounts with meals. Fluids, fibre and exercise help against constipation.
  • Have the increase postponed — the most effective adjustment. If a step remains hard going, the practice can keep you on the current dose for longer instead of increasing it as planned.
  • Do not step up other treatments that are hard on the gut at the same time — for example, do not increase metformin in the same week.

What does little good

Skipping meals altogether to avoid nausea often leads to cravings and bigger portions later on. Changing the time of injection makes little difference to nausea for most people — a fixed time is more important. Taking anti-sickness medicines on your own is not a good long-term solution: they mask the signal that the dose has been increased too quickly. If you are thinking of adding a medicine such as metoclopramide, that belongs in a conversation with the practice.

When nausea is no longer a transitional problem. If for more than a day you can barely keep fluids down, are vomiting heavily, are passing very little urine or have severe abdominal pain, this is not a case for toughing it out. Contact the practice promptly — dehydration can damage the kidneys, and severe pain may be caused by inflammation of the gallbladder or pancreas. More on assessment and warning signs under vomiting.

7. The stopping effect: what happens after you stop

Liraglutide is not addictive, and there are no withdrawal symptoms. Because its half-life is only about half a day, it has left the body within a few days of stopping — and its effect goes with it. That is precisely the stopping effect that is talked about too rarely before treatment begins.¹,³

  • Appetite: hunger and the feeling of fullness return to their previous level within days — many experience this as hunger that is suddenly "loud" again.
  • Weight: studies with GLP-1 receptor agonists show that, after stopping, a large part of the weight lost comes back within months for most people.
  • Blood sugar: in type 2 diabetes, blood sugar and HbA1c rise again unless another treatment takes over.

That does not mean the treatment was in vain — it means that liraglutide treats a chronic condition for as long as it is used, much as a blood pressure medicine lowers blood pressure for as long as you take it. The German obesity guideline therefore sees drug treatment as an addition to a lasting basic programme of diet, exercise and behavioural change, not as a replacement for it.³

Planning a stop rather than being caught out by it

  1. Build the foundations during treatment. The phase with less hunger is the best time to anchor new eating and exercise habits. Strength training and enough protein help you lose less muscle mass while you lose weight.
  2. Clarify the reason for stopping. Side effects, costs, a supply shortage, wanting children or goal reached? Depending on the reason, there are different follow-on solutions.
  3. Decide on follow-on treatment. In type 2 diabetes it must be clear beforehand what will lower blood sugar from then on.
  4. Agree a threshold for action. At what weight gain will the approach be discussed again? Weighing yourself regularly makes changes visible early.
An honest assessment: whether tapering the dose gradually prevents weight gain after stopping has not been demonstrated. It is not medically necessary, because there is no withdrawal to fear. Some practices nevertheless reduce in steps to make the transition gentler for the appetite. The basics of planned stopping are in the guide stopping medications.

8. Interactions

Liraglutide is not broken down by the liver enzymes that are responsible for many interactions. What matters most is the slower emptying of the stomach and the combination with other blood sugar-lowering medicines.¹

CombinationConsequenceWhat to do
Insulin, sulfonylureas such as glimepirideIncreased risk of hypoglycaemiaThe dose of these medicines is often reduced; measure blood sugar more often
Other GLP-1 receptor agonists, tirzepatideSame mechanism, more side effects without any meaningful added benefitDo not combine; a switch is planned by the doctor
DPP-4 inhibitors such as sitagliptinAlso act via the GLP-1 system, hardly any added benefitUsually not combined
Phenprocoumon and other coumarinsAltered absorption possibleAccording to the SmPC, check the INR more often at the start
Oral medicines that need to work quicklyDelayed absorption because of slower stomach emptying, usually without clinical significanceRaise it if you notice a change in effect
Contraceptive pillAccording to the SmPC, liraglutide itself does not change its effect to any relevant degree, but vomiting and severe diarrhoea can reduce its reliabilityFollow the rules for vomiting; see medications and contraception
SGLT2 inhibitors such as empagliflozin, diureticsHigher risk of dehydration with vomiting or diarrhoeaClarify with your doctor what to pause on sick days
AlcoholWorsens nausea; with insulin or sulfonylureas, risk of hypoglycaemia; puts a strain on the pancreasRestraint, especially during the dose-escalation phase
Table scrolls to the right

In type 2 diabetes, several medicines often come together — an up-to-date medication plan and an interaction check before every change help you keep track. The guide diabetes medications in daily life gives an overview of how diabetes medicines fit into everyday life.

9. Liraglutide, semaglutide, tirzepatide: how they differ

Liraglutide was one of the first GLP-1 receptor agonists to be widely used. There are now successors that are injected once a week. Here is the comparison at a glance — in more detail in the guide weight-loss injections compared:

Active ingredientMechanismUseAssessment
LiraglutideGLP-1 receptor agonistDailyShort half-life: side effects and effect wear off quickly after stopping; less weight loss in studies than its successors
SemaglutideGLP-1 receptor agonistWeekly (also as a tablet for diabetes)Greater weight loss than liraglutide in a head-to-head study
TirzepatideGIP and GLP-1 receptor agonistWeeklyDual mechanism; the greatest weight loss in this group in studies so far
Table scrolls to the right

So why liraglutide at all? Daily dosing allows finer dose steps, and if you tolerate side effects poorly, the medicine is out of your system faster after stopping than a weekly product. Then there are factors such as availability, the practice's experience and cost. A switch between the active ingredients is planned by the practice — combining or overlapping them on your own only increases the side effects.

10. Special situations: pregnancy, anaesthesia, kidneys, costs

Pregnancy, breastfeeding, wanting children

Liraglutide is not used in pregnancy; experience in humans is insufficient. In type 2 diabetes, treatment is usually switched to insulin when a pregnancy is planned or has begun, and weight reduction is not a goal during pregnancy anyway. Liraglutide is not recommended while breastfeeding either. So plan a wish for children with the practice in good time; embryotox offers individual advice.¹,⁶

Anaesthesia, gastroscopy and operations

Because liraglutide slows stomach emptying, the stomach may still contain food even after fasting. The European Medicines Agency has therefore pointed to a possible risk of stomach contents getting into the lungs during general anaesthesia or deep sedation.⁵ Say explicitly before any procedure that you inject liraglutide — whether and for how long it is paused beforehand is decided by the anaesthesia team. More in the guide medications before surgery.

Kidneys, liver, eyes

With impaired kidney function, depending on the product and the severity, either no adjustment is needed or use is not recommended; with severe liver impairment, liraglutide is not recommended. If you already have diabetic retinopathy, keep an eye on your eyes: a rapid fall in blood sugar can temporarily worsen changes in the retina — described mainly for another GLP-1 agent.¹

Costs, shortages and travel

In type 2 diabetes, statutory health insurance covers the cost. Under current law in Germany, however, medicines for weight reduction are generally excluded from reimbursement — the product for weight reduction is usually paid for privately. In recent years there have repeatedly been supply shortages of GLP-1 products; plan repeat prescriptions in good time. When travelling, the pen belongs in your hand luggage, protected from heat and frost, together with a doctor's certificate for the needles and the pen.

11. Liraglutide experiences: what patients really ask

"I've felt sick all the time since the last dose increase. Should I stop?"

Not straight away — but do not simply grit your teeth and take the next step as planned either. Nausea after an increase is very common and usually eases within days to a few weeks. The most effective adjustment is the pace: talk to your practice about staying on the current step for longer or temporarily going back to the previous one. Smaller, lower-fat meals and eating slowly help as well. It is a different matter if you can hardly drink any more, are vomiting heavily or have severe abdominal pain — then please have it checked by a doctor promptly.

"I put weight back on after stopping. Was it all for nothing?"

No, but the experience is typical and has a biological explanation: when the active ingredient goes, the additional satiety signal goes with it, and the body defends its previous weight with more hunger. That is not a personal failure. The question is what happens next: some return to treatment with medical support, others stabilise with a more intensive basic programme, and in type 2 diabetes another medicine may be an option. What you take away from the treatment period — eating habits, exercise, building muscle — keeps working without the injection.

"I'm afraid of injections. Does it hurt?"

The needles on liraglutide pens are very short and thin, and most people barely feel the prick. What is more often unpleasant is reused, blunt needles, cold solution straight from the fridge or a tensed-up skin fold. A fresh needle, a pen that has been left to reach room temperature for a few minutes and a relaxed injection site — that is usually enough. Have the first injection demonstrated at the practice or pharmacy; after a few days it becomes routine for most people.

Nausea, weight and blood sugar in one history

With a history, you discuss each dose step on the basis of data rather than memories.

Start tracking

FAQ: Common questions about liraglutide

According to the SmPC, liraglutide can be injected at any time of day, independently of meals. What matters is choosing a time you can keep to every day. Changing the time is possible but should be agreed with the practice or pharmacy.
For most people, nausea occurs mainly at the start and after each dose increase and eases within days to a few weeks. Smaller, lower-fat meals and eating slowly help. If it persists, the practice can postpone the increase or go back a step.
There are no withdrawal symptoms, but the effect disappears within a few days. Appetite returns, and for most people weight goes back up over the following months. In type 2 diabetes, blood sugar rises unless another treatment takes over. Stopping should therefore be planned with the practice.
According to the SmPC, a pen in use keeps for one month, at room temperature up to 30 degrees or in the fridge. Unopened pens are stored in the fridge but never frozen. A pen that has been frozen or overheated should no longer be used.
In type 2 diabetes, statutory health insurance covers the cost. Under current law in Germany, medicines for weight reduction are generally excluded from reimbursement, so the product for weight reduction is usually paid for out of your own pocket. Private insurers handle this in different ways.
Both are GLP-1 receptor agonists. Liraglutide is injected daily and has a short half-life; semaglutide is given once a week. In a head-to-head study, semaglutide led to greater weight loss. Which active ingredient fits better depends on the goal, tolerability and availability.

Sources

  1. Summaries of Product Characteristics (SmPC) for liraglutide (products for the treatment of type 2 diabetes and for weight management; current version). ema.europa.eu
  2. National Disease Management Guideline (Nationale VersorgungsLeitlinie) on type 2 diabetes (German Medical Association, National Association of Statutory Health Insurance Physicians, AWMF; current version) — German source. leitlinien.de
  3. S3 guideline on the prevention and treatment of obesity (German Obesity Society, AWMF reg. no. 050-001, current version) — German source. awmf.org
  4. Gesundheitsinformation.de (IQWiG): Type 2 diabetes — medicines and their side effects. Accessed 2026 — German source. gesundheitsinformation.de
  5. European Medicines Agency (EMA), Pharmacovigilance Risk Assessment Committee (PRAC): assessments of GLP-1 receptor agonists, including suicidal thoughts and the risk of aspiration during anaesthesia (2024). Accessed 2026. ema.europa.eu
  6. Embryotox, Charité — German pharmacovigilance and advisory centre on embryonic toxicology: liraglutide in pregnancy and breastfeeding. Accessed 2026. embryotox.de

Liraglutide, one step at a time — with brite

A daily reminder, a dose-escalation plan, a tolerability history and an interaction check in one place. Free.

Create medication plan
brite App
Medical disclaimer: This article is for general information and does not replace medical advice, diagnosis or treatment. Do not increase the dose of liraglutide on your own and do not combine it with other GLP-1 products. Stopping should be planned with the practice, because blood sugar and weight usually rise again afterwards. If you have severe, persistent upper abdominal pain, persistent vomiting with dehydration or signs of a severe allergic reaction, contact a doctor straight away or, in an emergency, call 112 (emergency number in Germany). Before any anaesthetic or gastroscopy, mention your liraglutide treatment. The choice of medicine and the dose are always set individually by the treating practice. Last updated: September 2026.